Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Net Cash Flow (2020 - 2025)

Bio Essence has reported Net Cash Flow over the past 6 years, most recently at -$28741.0 for Q4 2025.

  • Quarterly results put Net Cash Flow at -$28741.0 for Q4 2025, down 130.02% from a year ago — trailing twelve months through Dec 2025 was -$1371.0 (down 107.91% YoY), and the annual figure for FY2025 was -$1371.0, down 107.97%.
  • Net Cash Flow for Q4 2025 was -$28741.0 at Bio Essence, down from $28741.0 in the prior quarter.
  • Over the last five years, Net Cash Flow for BIOE hit a ceiling of $562629.0 in Q3 2023 and a floor of -$463957.0 in Q4 2023.
  • Median Net Cash Flow over the past 5 years was $451.0 (2022), compared with a mean of $9047.0.
  • Peak annual rise in Net Cash Flow hit 244514.1% in 2023, while the deepest fall reached 9560.38% in 2023.
  • Bio Essence's Net Cash Flow stood at -$26410.0 in 2021, then surged by 121.54% to $5690.0 in 2022, then tumbled by 8253.9% to -$463957.0 in 2023, then soared by 97.31% to -$12495.0 in 2024, then tumbled by 130.02% to -$28741.0 in 2025.
  • The last three reported values for Net Cash Flow were -$28741.0 (Q4 2025), $28741.0 (Q3 2025), and -$1371.0 (Q1 2025) per Business Quant data.